Literature DB >> 16397076

Growth hormone and its disorders.

J Ayuk1, M C Sheppard.   

Abstract

Growth hormone (GH) is synthesised and secreted by the somatotroph cells of the anterior lobe of the pituitary gland. Its actions involve multiple organs and systems, affecting postnatal longitudinal growth as well as protein, lipid, and carbohydrate metabolism. GH hypersecretion results in gigantism or acromegaly, a condition associated with significant morbidity and mortality, while GH deficiency results in growth retardation in children and the GH deficiency syndrome in adults. This article, aimed at non-paediatric physicians, examines the clinical features, diagnosis, and current concepts in the management of these conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397076      PMCID: PMC2563724          DOI: 10.1136/pgmj.2005.036087

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  94 in total

Review 1.  Acromegaly and cancer: not a problem?

Authors:  S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

2.  Colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; P D Fairclough
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

3.  Screening colonoscopy for acromegaly in perspective.

Authors:  A G Renehan; S T Odwyer; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

4.  Risk factors for glucose intolerance in active acromegaly.

Authors:  A Kreze; E Kreze-Spirova; M Mikulecky
Journal:  Braz J Med Biol Res       Date:  2001-11       Impact factor: 2.590

5.  The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.

Authors:  S R Peacey; A A Toogood; J D Veldhuis; M O Thorner; S M Shalet
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

6.  Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.

Authors:  A J van der Lely; R K Hutson; P J Trainer; G M Besser; A L Barkan; L Katznelson; A Klibanski; V Herman-Bonert; S Melmed; M L Vance; P U Freda; P M Stewart; K E Friend; D R Clemmons; G Johannsson; S Stavrou; D M Cook; L S Phillips; C J Strasburger; S Hackett; K A Zib; R J Davis; J A Scarlett; M O Thorner
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

7.  Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.

Authors:  A Colao; D Ferone; P Marzullo; P Cappabianca; S Cirillo; V Boerlin; I Lancranjan; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

8.  Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly.

Authors:  R Cozzi; M Barausse; M Sberna; A Lodrini; A Franzini; G Lasio; R Attanasio
Journal:  Pituitary       Date:  2000-12       Impact factor: 4.107

9.  Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.

Authors:  J Kreutzer; M L Vance; M B Lopes; E R Laws
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

10.  Occurrence of ventricular late potentials in patients with active acromegaly.

Authors:  B L Herrmann; C Bruch; B Saller; S Ferdin; N Dagres; C Ose; R Erbel; K Mann
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

View more
  13 in total

1.  MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients.

Authors:  Maria Luisa Torre; Giuseppina T Russo; Marta Ragonese; Annalisa Giandalia; Ernesto De Menis; Giorgio Arnaldi; Angela Alibrandi; Carmelo Buda; Giovanni Romanello; Elisabetta L Romeo; Domenico Cucinotta; Francesco Trimarchi; Salvatore Cannavo
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

2.  Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice.

Authors:  Takahiro Fujimoto; Kyoko Miyasaka; Midori Koyanagi; Toshiyuki Tsunoda; Iwai Baba; Keiko Doi; Minoru Ohta; Norihiro Kato; Takehiko Sasazuki; Senji Shirasawa
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

Review 3.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

4.  Differential gene signature in adipose tissue depots of growth hormone transgenic mice.

Authors:  Silvana Duran-Ortiz; Jonathan A Young; Adam Jara; Elizabeth A Jensen; Reetobrata Basu; Edward O List; Yanrong Qian; John J Kopchick; Darlene E Berryman
Journal:  J Neuroendocrinol       Date:  2020-10-12       Impact factor: 3.627

5.  Oral manifestations in growth hormone disorders.

Authors:  Gaurav Atreja; Shikha Handa Atreja; Nitul Jain; Urvashi Sukhija
Journal:  Indian J Endocrinol Metab       Date:  2012-05

Review 6.  Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.

Authors:  Maria Fleseriu
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

7.  Gene Expression Signature in Adipose Tissue of Acromegaly Patients.

Authors:  Irit Hochberg; Quynh T Tran; Ariel L Barkan; Alan R Saltiel; William F Chandler; Dave Bridges
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

8.  Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine.

Authors:  Pablo Martín-Gago; Álvaro Rol; Toni Todorovski; Eric Aragón; Pau Martin-Malpartida; Xavier Verdaguer; Mariona Vallès Miret; Jimena Fernández-Carneado; Berta Ponsati; Maria J Macias; Antoni Riera
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

9.  Dietary Energy Levels Affect Growth Performance through Growth Hormone and Insulin-Like Growth Factor 1 in Yak (Bos grunniens).

Authors:  Chao Yang; Jianbo Zhang; Anum Ali Ahmad; Pengjia Bao; Xian Guo; Ruijun Long; Xuezhi Ding; Ping Yan
Journal:  Animals (Basel)       Date:  2019-01-28       Impact factor: 2.752

10.  A microarray gene analysis of peripheral whole blood in normal adult male rats after long-term GH gene therapy.

Authors:  Ying Qin; Ya-Ping Tian
Journal:  Cell Mol Biol Lett       Date:  2010-01-28       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.